ERBB2 and breast cancer: Deregulated lipid metabolism and enhanced FA synthesis have been described in different types of breast cancer: for example, FASN can be upregulated by HER2 signalling and induced by sterol regulatory element-binding protein 1 (SREBP1) [22] under the control of mTOR.